stockrowSarepta Therapeutics, Inc.
SRPT Healthcare Biotechnology
Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024.
- Revenue
- −4.51%
- EPS
- +46.0%
- Free cash flow
- +231.8%
- Total debt
- −17.2%
Quarter to September 2026, against a year earlier
Follow SRPT
Alert me
Sarepta Therapeutics, Inc. (SRPT) EV/FCF
As of 6 November 2026, Sarepta Therapeutics, Inc. (SRPT) trades at a EV/FCF of 10.9×. Over the past ten years it has ranged from −39.1× (June 2018) to 92.7× (December 2020); the current reading is higher than 87% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | −6.8× | — |
| FY2024 | −32.4× | — |
| FY2023 | −17.4× | — |
| FY2022 | −29.2× | — |
| FY2021 | −16.5× | — |
| FY2020 | 92.7× | — |
| FY2019 | −17.5× | — |
| FY2018 | −14.3× | — |
| FY2017 | −21.7× | — |
| FY2016 | −4.1× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 11.3× | (58.73%) |
| Jun 2026 | 27.3× | 15.29% |
| Mar 2026 | 23.7× | — |
| Dec 2025 | −6.8× | — |
| 35 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| MRVI Maravai LifeSciences Holdings, Inc. compare | −97.6× |
| TRVI Trevi Therapeutics, Inc. compare | −36.2× |
| MAZE Maze Therapeutics, Inc. compare | −15.4× |
| TRAX First Tracks Biotherapeutics, Inc. compare | −13.8× |
| MESO Mesoblast Limited compare | −13.1× |
| VIR Vir Biotechnology, Inc. compare | −11.3× |
| REPL Replimune Group, Inc. compare | −8.5× |
| HRMY Harmony Biosciences Holdings, Inc. compare | 4.6× |
| SRPT Sarepta Therapeutics, Inc. | 10.9× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))